Skip to main content
. 2022 Oct 15;23(20):12358. doi: 10.3390/ijms232012358
ADC Antibody-drug conjugate
ADCC Antibody-dependent cell-mediated cytotoxicity
CDC Complement-dependent cytotoxicity
DAR Drug-to-antibody ratio
EOC Epithelial ovarian cancer
IC50 Half-maximal inhibitory concentration
PVRIG Poliovirus receptor-related immunoglobulin domain-containing
SPR Surface plasmon resonance